Mark J. Rosenblum, Executive VP Finance, CFO at Salarius Pharmaceuticals, Inc. (SLRX), bought 76,246 shares at $0.39 ($30K) on 2022-03-03, disclosed to the SEC on 2022-03-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| SLRX | BUY | 2020-08-18 | $5K | — | Filing → |
| SLRX | BUY | 2020-02-20 | $2K | — | Filing → |
| SLRX | BUY | 2020-02-13 | $4K | — | Filing → |